Boxer Capital Management’s Regenxbio RGNX Stock Holding History

Boxer Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Hold	15,000	–	–	0.01%	62
2026 Q1	$126K	Buy	+15,000	New	+$158K	0.02%	53

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Boxer Capital Management's RGNX Position: Q2 2026 in Review

Boxer Capital Management held its Regenxbio (RGNX) position steady in Q2 2026 at 15,000 shares worth $180K. The position accounts for 0.01% of the portfolio, ranked #62.

Boxer Capital Management first reported a position in RGNX in Q1 2026 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Boxer Capital Management held 15,000 shares of Regenxbio worth $180K as of Q2 2026.
Boxer Capital Management left its Regenxbio share count unchanged in Q2 2026.
Regenxbio made up 0.01% of Boxer Capital Management's portfolio in Q2 2026, its #62 holding.
Boxer Capital Management first reported a position in Regenxbio in Q1 2026 and has held it in 2 quarters since.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.